I develop innovative, effective, and data-driven proposal, pricing, and profitability strategies for high-growth clinical research companies. As such, I am an expert in all aspects of commercial business and proposal development, as well as associated analytics and modeling.My legacy at ICON includes the talented teams, foundational operational processes, and profitable proposal and pricing strategies I have implemented during my tenure. I partner often with executive leaders to execute highly strategic initiatives and programs that positively impact our entire organization. My big-picture perspective, vast experience in multiple business development functions, and global network of relationships makes me a valuable partner in the business and a key growth driver in an increasingly competitive marketplace.Key Strengths:✔ CHANGE MANAGEMENT – The global pharmaceutical and clinical research industries are changing faster than ever, with new research models, partner networks, and service structures emerging each year. I am an expert at adapting our business development, proposals, and pricing models to maintain excellent performance and growth in an increasingly competitive area. One of my most valuable skills is finding a way forward in crisis scenarios.✔ CONTINUOUS IMPROVEMENT – I believe that process must have a purpose. I advocate for clear, effective, well-documented processes that make it easier for all stakeholders to deliver on their goals. During my 10-year tenure at ICON, I designed and implemented fully customized, data-driven pricing strategies and advanced pricing tools for four service lines—then maintained those strategies as the businesses grew and changed over time. ✔ TEAM BUILDING – Even the most well-designed operation will fail without incredible, passionate people running the business from day to day. With more than a decade of leadership experience, I excel at developing and motivating strong teams that embody our mission and values. In several cases, I took over a newly established or recently acquired team and led them to surpass all expectations.